Intrinsiqq
Avanos Medical Inc. logo

Avanos Medical Inc. Financials

AVNS

⊜ Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 15 available years
Income Statement
TTM
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
Revenue$716$701$688$673$684$587
Cost of Revenue$358$347$307$294$290$288
Gross Profit$358$354$381$380$394$299
General & Administrative$318$316$319$335$327$285
Research & Development$23$23$26$27$29$31
Provision for Doubtful Accounts$0$1$1$1$1-$1
Other Operating Expenses-$4$0$4-$13-$3-$22
Total Operating Expenses$779$763$1,084$669$649$626
Operating Income-$63-$62-$396$4$36-$39
Non-Operating
Net Interest Expense-$5-$5-$7-$12-$9-$3
Other Non-Operating Income (Expense)$0$0$0$0$0$0
EBT (Earnings Before Tax)-$68-$66-$403-$8$27-$42
Income Tax Expense$6$7-$17$2$5-$11
Earnings from Continuing Ops–-$73-$386-$10$22-$31
Net Income
Net Income-$74-$73-$392-$62$51$6
Per Share Data
Revenue Per Share$15.07$15.14$14.95$14.45$14.46$12.08
EPS (Basic)-$1.60-$1.57-$8.53-$1.32$1.08$0.13
EPS (Diluted)-$1.60-$1.57-$8.53-$1.32$1.07$0.13
Weighted Avg Shares (Basic)46.5M46.3M46.0M46.6M46.9M48.1M
Weighted Avg Shares (Diluted)47.5M46.3M46.0M46.6M47.3M48.6M
Shares Outstanding47.5M46.3M46.0M46.6M47.3M48.6M

Avanos Medical (AVNS) financials: revenue, profit and margins

Avanos Medical (AVNS) generated about $716 million in revenue and -$74 million in net income (a -10.4% net margin) over the trailing twelve months, growing at roughly -0.4% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

What is Avanos Medical's (AVNS) revenue?+

Avanos Medical generated about $716 million in revenue over the trailing twelve months. Revenue has grown at roughly -0.4% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Avanos Medical profitable?+

Avanos Medical reported about -$74 million in net loss over the trailing twelve months, a net margin of roughly -10.4%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Avanos Medical's profit margins?+

Avanos Medical runs a gross margin of about 50.0%, an operating margin of about -8.8%, a net margin of about -10.4%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Avanos Medical growing?+

Avanos Medical's revenue has compounded at roughly -0.4% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside AVNS's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 28 Apr 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 9 Jul 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Pick stocks to compare with AVNS

CompareIntrinsic value
CDRECadre Holdings Inc.
$30.84-0.71%63
INGNInogen Inc.
$7.22+2.85%25
ESTAEstablishment Labs Holdings Inc.
$66.94+9.02%30
LAKELakeland Industries Inc.
$8.93-0.11%15
SMTISanara MedTech Inc.
$32.33+0.50%51
MSAMsa Safety Inc.
$177.60+2.03%75
ENOVEnovis Corporation
$24.42+16.90%42
ALGNAlign Technology, Inc.
$164.90+8.79%66

Held by ETFs

AVNS is in 15 US ETFs. The largest of them, with AVNS's weight in each:

Spot a number that looks wrong? Check it in AVNS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AVNS

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.